Executive Briefing Archives - Page 6 of 148 - IBO

UK Investigates Thermo Fisher Scientific Acquisition

October 31, 2018/0 Comments/in Volume 27, Issue 14 Legal, M&A Executive Briefing, Mergers and Acquisitions Executive Briefing, M&A Executive Briefing /by admin

Competition concerns cited

Twist Sets IPO Price

October 31, 2018/0 Comments/in Volume 27, Issue 14 Financial, Legal Executive Briefing /by admin

Company expected to raise over $100 million

Drug Maker Invests in Oxford Nanopore

October 31, 2018/0 Comments/in Volume 27, Issue 14 Sequencing Executive Briefing /by admin

Company continues its fund-raising streak

Twist Bioscience to Go Public

October 15, 2018/0 Comments/in Volume 27, Issue 13 Financial Executive Briefing /by admin

Company annual revenues more than double

US ITC Rules Against 10x Genomics

October 15, 2018/0 Comments/in Volume 27, Issue 13 Legal Executive Briefing /by admin

Decision affects Bio-Rad patents

Brooks Automation Expands to Include Genomic Testing Services

October 12, 2018/0 Comments/in Volume 27, Issue 13 M&A Executive Briefing, Mergers and Acquisitions Executive Briefing /by admin

Company makes $450 million acquisition

Agilent Technologies Enters Flow Cytometer Market

September 30, 2018/0 Comments/in Volume 27, Issue 12 Cell-based Analysis, M&A Executive Briefing, Mergers and Acquisitions Executive Briefing, M&A Executive Briefing /by admin

Agilent gains Chinese facilities

Lab Automation Specialist TTP Labtech Acquired

September 30, 2018/0 Comments/in Volume 27, Issue 12 Cell-based Analysis, Laboratory Automation, M&A Executive Briefing, Mergers and Acquisitions Executive Briefing, M&A Executive Briefing /by admin

Company obtains new funding for acquisitions

LGC Adds to Oligo Business

September 30, 2018/0 Comments/in Volume 27, Issue 12 Life Science Consumables, M&A Executive Briefing, Mergers and Acquisitions Executive Briefing, M&A Executive Briefing /by admin

Acquisition provides new North American opportunities

QIAGEN to Sell Novel PCR Instrumentation

September 30, 2018/0 Comments/in Volume 27, Issue 12 Diagnostics, Nucleic Acid Amplification Executive Briefing, M&A Executive Briefing /by admin

QIAGEN buys NeuMoDx